Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
58.55
+0.76 (1.32%)
At close: Aug 27, 2026

SHA:688192 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
179.14291.42250.1674.2121.67364.24
Trading Asset Securities
1,5571,645589.836741,2951,711
Cash & Short-Term Investments
1,7361,936839.99748.21,4162,075
Cash Growth
-22.87%130.51%12.27%-47.18%-31.74%246.26%
Accounts Receivable
210.67143.4427.4948.04-7.55
Other Receivables
3.83-----
Receivables
214.49143.4427.4948.04-7.55
Inventory
42.936.9544.1123.475.07-
Other Current Assets
63.8866.0387.3790.6551.6429.57
Total Current Assets
2,0572,183998.97910.361,4732,112
Property, Plant & Equipment
366.95381.23243.91102.26103.66104.48
Other Intangible Assets
379.89396.43429.85461.98492.02474.9
Long-Term Deferred Charges
2.894.098.6216.997.994.54
Other Long-Term Assets
40.8338.0937.384.795.0649.51
Total Assets
2,8483,0031,7191,4962,0822,746

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
199.5734.8220.3918.578.811.65
Accrued Expenses
75.21331.8245.07182.18208.53182.75
Short-Term Debt
48.91217.45373.83200.11--
Current Portion of Long-Term Debt
381.59291.9741.270.1--
Current Portion of Leases
-21.223.5322.9521.3416.84
Current Income Taxes Payable
15.961.34-0.050-
Current Unearned Revenue
8.855.52.930.98--
Other Current Liabilities
53.181.1478.0623.499.8210.76
Total Current Liabilities
783.19985.23785.08448.44248.49211.99
Long-Term Debt
913.17688.15683.76138.31--
Long-Term Leases
11.4421.9834.9948.8963.9370.92
Long-Term Unearned Revenue
10.9411.4814.8412.1111-
Total Liabilities
1,7191,7071,519647.75323.43282.91

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
465.17461.19417.65408.15407.16404.18
Additional Paid-In Capital
4,9994,9563,1362,9542,7572,729
Retained Earnings
-4,334-4,124-3,360-2,514-1,406-669.85
Total Common Equity
1,1301,294193.76848.631,7582,463
Minority Interest
-0.891.836.3---
Shareholders' Equity
1,1291,296200.06848.631,7582,463
Total Liabilities & Equity
2,8483,0031,7191,4962,0822,746

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,3551,2411,157410.3785.2787.76
Net Cash (Debt)
380.92695.51-317.39337.831,3311,987
Net Cash Growth
-64.49%---74.62%-33.02%231.62%
Net Cash Per Share
0.821.56-0.770.833.295.52
Filing Date Shares Outstanding
479.96461.19417.65408.15407.16404.18
Total Common Shares Outstanding
479.96461.19417.65408.15407.16404.18
Working Capital
1,2741,197213.89461.931,2251,900
Book Value Per Share
2.352.810.462.084.326.09
Tangible Book Value
750.12897.43-236.09386.651,2661,988
Tangible Book Value Per Share
1.561.95-0.570.953.114.92
Buildings
-227.2----
Machinery
-160.6755.4349.1431.9926.91
Construction In Progress
--169.7213.358.855.04